All news

Palvella Therapeutics Officer Jeffrey Martini Files Form 144 to Sell 50,000 Shares via Rule 144

Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash

Jeffrey Martini, an officer at Palvella Therapeutics, Inc., has filed a Form 144 to sell 50,000 shares of common stock. The transaction, valued at $8,704,000.00, will be conducted under Rule 144 of the Securities Act of 1933 and a Rule 10b5-1 trading plan adopted in July 2026. These shares are derived from the exercise of stock options.

Read original source

PVLA company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.